Extracellular vesicles — lipid-enclosed nanoparticles that cells use for communication — operate as double-edged molecular messengers in aging processes. EVs from senescent or diseased cells actively propagate the hallmarks of aging: chronic inflammation, oxidative stress, genomic damage, and mitochondrial dysfunction. These pathogenic vesicles essentially broadcast cellular decay throughout tissues, accelerating age-related deterioration. However, EVs from stem cells and young healthy tissues demonstrate the opposite effect, delivering rejuvenating cargo that restores cellular balance, enhances mitochondrial function, and promotes tissue regeneration. This dual nature positions EVs at the center of aging biology, suggesting they may be both culprits and potential cures. The therapeutic implications are compelling — engineered EVs could theoretically deliver anti-aging interventions directly to target tissues. Yet significant hurdles remain, particularly rapid clearance from the bloodstream and inefficient targeting to specific organs. This represents confirmatory science that solidifies EVs as key players in aging, while opening promising but still experimental avenues for regenerative medicine. The field needs more clinical trials to translate these mechanistic insights into practical anti-aging therapies.